It's your blog, but by only highlighting complement you are grossly undervaluing the multiple beneficial pathways altered by apabetalone. Although these pathways are complimentary to one another, they are not dependent on complement. These other pathways are in addition to, not because of, an altered complement pathway. It sounds like you are misinterpreting the Beacon report. In an effort to keep it simple you are instead omitting some of the most important cardioprotective pathways. I would still advise you to at least list all six of the major pathways in that diagram. Maybe even link to the Resverlogix publications page. 

BearDownAZ